TGThe Guardian·1hBusiness
score+0.10
AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger
Original
AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger
“The headline uses factual, transactional language regarding a corporate merger without employing emotional framing, alarmism, or celebratory hype.”